Biosimilars 2021 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Biosimilar Code Name. Introduction. 2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Yet, given fewer FDA approvals in 2020 and 2021, this year saw the lowest number of commercial launches since 2017.
52 
Let's personalize your content